Fairvalue-Calculator Fairvalue-Calculator
EN DE

Anhui Huaren Health Pharmaceutical Co (301408) Fair Value & Analysis

Healthcare · CN · Market cap 6.3B CNY

Price¥15.33
Fair Value¥14.79
Upside-3.5%
Quality93/100
Evidence: High Range ¥10.76 – ¥18.82

Analysis

Anhui Huaren Health Pharmaceutical Co (301408) currently trades at ¥15.33, while our model-based Fair Value estimate is ¥14.79 — implying the stock looks roughly 3.5% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in 2001 and is based in Hefei, China.

Open the full interactive analysis →

Similar stocks

JD Health International Inc (JDHIF) +376% Alibaba Health Information Technology Limited (ALBBY) -20% Raia Drogasil S.A (RADL3) -8% Yifeng Pharmacy Chain Co (603939) +106% Clicks Group (CLCGY) +45% Sugi Holdings (SGIPF) +98%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.